All In Biotech

Drug Trial Radar · NCT06669091

Food-effect Study of Ecopipam Pharmacokinetics

A Phase 1, Randomized, 2-way Crossover, Food-effect Study of Ecopipam Pharmacokinetics After Administration of the to Be Marketed Tablet in Healthy Subjects

Last checked: Nov 19, 2026Latest source record: Jan 27, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

25

Actual

Start

Nov 5, 2024

Primary completion

Dec 22, 2024

Study completion Dec 27, 2024

Sponsor

Lead sponsor
Emalex Biosciences Inc.Industry
Sponsor type
Industry
First posted
Nov 1, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Crossover
Masking
None
Primary purpose
Basic science
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 55 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

Standard food-effect study to identify the effect of food on ecopipam pharmacokinetics after administration of a to-be-marketed ecopipam tablet in healthy volunteers.

Conditions

  • Food-effect

Interventions

  • Ecopipam tabletDrug

    A single ecopipam 89.6 mg tablet (equivalent to ecopipam HCl 100 mg)

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Cmax of ecopipam after administration of an ecopipam tablet in the fed stateTime frame: Up to Day 13
  2. Tmax of ecopipam after administration of an ecopipam tablet in the fed stateTime frame: Up to Day 13
  3. AUC of ecopipam after administration of an ecopipam tablet in the fed stateTime frame: Up to Day 13
  4. AUCinf of ecopipam after administration of an ecopipam tablet in the fed stateTime frame: Up to Day 13
  5. AUClast of ecopipam after administration of an ecopipam tablet in the fed stateTime frame: Up to Day 13
  6. Cmax of ecopipam after administration of an ecopipam tablet in the fasted stateTime frame: Up to Day 13
  7. Tmax of ecopipam after administration of an ecopipam tablet in the fasted stateTime frame: Up to Day 13
  8. AUC of ecopipam after administration of an ecopipam tablet in the fasted stateTime frame: Up to Day 13
  9. AUClast of ecopipam after administration of an ecopipam tablet in the fasted stateTime frame: Up to Day 13
  10. AUCinf of ecopipam after administration of an ecopipam tablet in the fasted stateTime frame: Up to Day 13

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • ICON Early Phase Services

    San Antonio, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.